Vylor (NYSE:VYLR) Upgraded at UBS Group

Vylor (NYSE:VYLR) was upgraded by investment analysts at UBS Group to a “strong-buy” rating in a note issued to investors on Monday, Zacks reports.

VYLR has been the topic of several other reports. Wolfe Research upgraded shares of Vylor to a “strong-buy” rating in a research report on Thursday, October 1st. BNP Paribas Exane began coverage on shares of Vylor in a research report on Wednesday. They issued a “neutral” rating on the stock. Zacks Research upgraded shares of Vylor to a “hold” rating in a research report on Monday, October 5th. BMO Capital Markets initiated coverage on Vylor in a research report on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Vylor in a report on Wednesday. They issued a “buy” rating and a $90.00 target price on the stock. Three analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $83.36.

Vylor Price Performance

Shares of Vylor stock opened at $76.59 on Monday. Vylor has a 52-week low of $65.00 and a 52-week high of $77.39.

About Vylor

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.